Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
TORONTO and CHICAGO, April 18, 2023 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals (TSX:MDP; OTCQX: MEDXF) is pleased to announce that company management will be participating in the 2023 Bloom Burton & Co. Healthcare Investor Conference from April 25 to 26, 2023.
Related news for (MEDXF)
- Medexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Update
- Medexus Announces New License Deal for Topical Terbinafine
- Medexus Announces US$58.5 million in New Credit Facilities
- Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022